Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CASSAVA SCIENCES INC | Chief Clinical Dev. Officer | Stock Option (Right to Buy) | 85K | $1.43M | $16.87 | Nov 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SAVA | CASSAVA SCIENCES INC | Nov 18, 2024 | 1 | $0 | 4 | Nov 20, 2024 | Chief Clinical Dev. Officer |
SAVA | CASSAVA SCIENCES INC | Nov 18, 2024 | 0 | $0 | 3 | Nov 20, 2024 | Chief Clinical Dev. Officer |